Although our results need validation in larger patient cohorts, they show the potential of the VIP/VPAC axis in the diagnosis of IMID and open a line of research based on its association with miRNA signatures in autoimmune diseases, providing an innovative approach in the management of these disorders as a whole given their shared common mechanisms. Here, VIP is linked to autoimmune disease.